BioMarin Pharmaceutical Inc (BMRN) Capital expenditures 2016–2025
BioMarin Pharmaceutical Inc (BMRN) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$103.0MFY2025 · since FY2016: $148.4M → $103.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $103.0M | +20.6% |
| FY2024 | $85.4M | -11.7% |
| FY2023 | $96.7M | -20.1% |
| FY2022 | $121.0M | +26.6% |
| FY2021 | $95.6M | -16.4% |
| FY2020 | $114.3M | -21.2% |
| FY2019 | $145.0M | +0.3% |
| FY2018 | $144.6M | -27.4% |
| FY2017 | $199.2M | +34.3% |
| FY2016 | $148.4M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice